Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: NEOMATRIX THERAPEUTICS INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-09-09 to 2025-09-08
Current total value of award: $2923902
Description: RESEARCH AND DEVELOPMENT FOR CNP8 FOR BURN INJURY IN SUPPORT OF JPC-6/CCCRP AT CDMRP.